Loading publications…
The last 5 uploaded publications
Captions from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes (2023). Captions from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells. , DOI: https://doi.org/10.1158/1535-7163.22504327.v1.
Preprint74 days ago'Supplementary Methods' from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes (2023). 'Supplementary Methods' from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells. , DOI: https://doi.org/10.1158/1535-7163.22504333.v1.
Preprint74 days agoSupplementary Figures S1, S2 and S3 from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes (2023). Supplementary Figures S1, S2 and S3 from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells. , DOI: https://doi.org/10.1158/1535-7163.22504324.v1.
Preprint74 days agoMYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
Pedro Blecua, Verónica Dávalos, Manel Esteller, Eva Pros, Paula Llabata, Manuel Torres-Diz, Anna Esteve‐Codina, Montse Sánchez‐Céspedes, Juan J. Alburquerque-Béjar, Pablo Navajas-Chocarro, Maria Saigí, Ana Ferrero-Andres, Juan M. Morillas, Andrea Vilarrubi, Antonio Gómez, José Luís Mate, Ana M Muñoz‐Mármol, Octavio A. Romero (2023). MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer. , 4(4), DOI: https://doi.org/10.1016/j.xcrm.2023.101006.
Article74 days ago'Supplementary Methods' from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
Pol Giménez‐Xavier, Eva Pros, Ester Bonastre, Sebastián Morán, Ana Aza, Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, Diana Salinas-Chaparro, Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes (2023). 'Supplementary Methods' from Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells. , DOI: https://doi.org/10.1158/1535-7163.22504333.
Preprint74 days ago